Showing 1 - 6 of 7 results for: psilocybin
GDS2022: Spikey, succulent psychedelics; San Pedro and Peyote, the mescaline cacti
gds-2022
Dr Liam Engel Professor & Professor Adam Winstock While the media having been following the traditional psychedelic renaissance for the last few years, focusing
Micro-dosing – how do you do it, and what are your experiences?
gds-2021
Microdosing with psychedelics is no longer the shiny new thing it was when we first looked at it in 2016. It’s everywhere. Online guides,
GDS 2020: Are psychedelics your medicine?
gds-2020
Prof Adam R Winstock, Consultant Psychiatrist and Global Drug Survey CEO, Associate Prof Matt Johnson, John Hopkins University Dr Ben Sessa, Consultant Psychiatrist, University
GDS2019: The psychedelic revolution in psychiatry and why patient opinion matters so much
gds-2019
Professor Adam R Winstock and Associate Professor Matthew W. Johnson In the last 12 months a formulation of ketamine has received FDA approval for
GDS2019: Psychedelic micro-dosing: the good, the bad and the who knows what.
gds-2019
Professor Adam R Winstock What a decade it has been for psychedelics. From new studies shining a light on their therapeutic applications and imaging
GDS2019: Would you take a trip to help heal your mind? Psychedelics in psychiatry
gds-2019
Professor Adam R Winstock, Dr Rupert McShane, Dr Ben Sessa & Associate Professor Matt Johnson Between us we’ve been practicing psychiatry and psychology for